Hepatitis B virus reactivation with a rituximab-containing regimen

被引：60
作者：
Tsutsumi, Yutaka [1 ]
Yamamoto, Yoshiya [2 ]
Ito, Shinichi [1 ]
Ohigashi, Hiroyuki [1 ]
Shiratori, Souichi [1 ]
Naruse, Hirohito [2 ]
Teshima, Takanori [3 ]
机构：
[1] Hakodate Municipal Hosp, Dept Hematol, 1-10-1 Minato Cho, Hakodate, Hokkaido 0418680, Japan
[2] Hakodate Municipal Hosp, Dept Gastroenterol, Hakodate, Hokkaido 0418680, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido 0600808, Japan
来源：
WORLD JOURNAL OF HEPATOLOGY | 2015年 / 7卷 / 21期
关键词：
Rituximab; Hepatitis B virus; Reactivation; Nucleoside analog; Non-Hodgkin's lymphoma;
D O I：
10.4254/wjh.v7.i21.2344
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Rituximab is currently used not only in the treatment of B-cell lymphoma but also for various other diseases, including autoimmune diseases, post-transplant graft vs host disease, and rejection following kidney transplants. Due to rituximab's widespread use, great progress has been made regarding research into complications that arise from its use, one of the most serious being the reactivation of hepatitis B virus (HBV), and efforts continue to establish guidelines for preventive treatment against this occurrence. This report discusses preventive measures against rituximab-induced HBV reactivation and future objectives.
引用
收藏
页码：2344 / 2351
页数：8
相关论文
共 72 条
[51]   Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. [J].
Suzan, F ;
Ammor, M ;
Ribrag, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :1000-1000
[52]   MASSIVE HEPATIC-NECROSIS AFTER CHEMOTHERAPY WITHDRAWAL IN A HEPATITIS-B VIRUS CARRIER [J].
THUNG, SN ;
GERBER, MA ;
KLION, F ;
GILBERT, H .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (07) :1313-1314
[53]   Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation [J].
Tillmann, HL ;
Wedemeyer, H ;
Manns, MP .
JOURNAL OF HEPATOLOGY, 2003, 39 :S206-S211
[54]   Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma [J].
Tsutsumi, Y ;
Tanaka, J ;
Kawamura, T ;
Miura, T ;
Kanamori, H ;
Obara, S ;
Asaka, M ;
Imamura, M ;
Masauzi, N .
ANNALS OF HEMATOLOGY, 2004, 83 (01) :58-60
[55]   Hepatitis B virus reactivation in a case of Non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy [J].
Tsutsumi, Y ;
Kawamura, T ;
Saitoh, S ;
Yamada, M ;
Obara, S ;
Miura, T ;
Kanamori, H ;
Tanaka, J ;
Asaka, M ;
Imamura, M ;
Masauzi, N .
LEUKEMIA & LYMPHOMA, 2004, 45 (03) :627-629
[56]  
Tsutsumi Y, 2010, HEPAT RES TREAT, V2010
[57]  
Tsutsumi Yutaka, 2005, Expert Opin Drug Saf, V4, P599, DOI 10.1517/14740338.4.3.599
[58]   Hepatitis B virus reactivation with rituximab-containing regimen [J].
Tsutsumi, Yutaka ;
Yamamoto, Yoshiya ;
Shimono, Joji ;
Ohhigashi, Hiroyuki ;
Teshima, Takanori .
WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (11) :612-620
[59]   HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine [J].
Tsutsumi, Yutaka ;
Ogasawara, Reiki ;
Miyashita, Naohiro ;
Tanaka, Junji ;
Asaka, Masahiro ;
Imamura, Masahiro .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (05) :588-591
[60]   Prevention of hepatitis B virus reactivation under rituximab therapy [J].
Tsutsumi, Yutaka ;
Yamamoto, Yoshiya ;
Tanaka, Junji ;
Asaka, Masahiro ;
Imamura, Masahiro ;
Masauzi, Nobuo .
IMMUNOTHERAPY, 2009, 1 (06) :1053-1061
12345678